Showing results (101-110 of 352) with videos related to
Sort By:
Pageof 36
Neuropsychiatric Disease and Treatment|September 14, 2022
Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber SurveyMaryia Zhdanava, H Lynn Starr, Todor I Totev, et al.Advances in Therapy|August 18, 2012
Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patientsFrançois Laliberté, Winnie W Nelson, Patrick Lefebvre, et al.Current Medical Research and Opinion|August 17, 2023
Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapyMark J Alberts, Maryia Zhdanava, Dominic Pilon, et al.Pharmacoeconomics|May 13, 2015
Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology AssessmentGregory Kruse, Bruce J O Wong, Mei Sheng Duh, et al.The Journal of Clinical Psychiatry|February 24, 2018
Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims DatabaseTony B Amos, Neeta Tandon, Patrick Lefebvre, et al.Current Medical Research and Opinion|July 28, 2015
Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medicationsConcetta Crivera, Winnie W Nelson, Brahim Bookhart, et al.The American Journal of Cardiology|October 9, 2023
Real-World Incidence of Adverse Clinical Outcomes Among People With Coronary Artery Disease and/or Peripheral Artery Disease in Relation to Vascular Risk in the United StatesUrvi Desai, Aram Babcock, Yao Wang, et al.Current Medical Research and Opinion|April 27, 2016
Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based studyPatrick Lefebvre, Dominic Pilon, Marie-Noëlle Robitaille, et al.Current Medical Research and Opinion|February 13, 2025
Real-world prevalence of potential drug-drug interactions associated with oral advanced therapies indicated for ulcerative colitisMaryia Zhdanava, Sabree Burbage, Todor I Totev, et al.Plos One|October 11, 2019
Burden of treatment-resistant depression in Medicare: A retrospective claims database analysisDominic Pilon, Kruti Joshi, John J Sheehan, et al.Pageof 36